If you are a patient or caregiver who was helped by the GDATF in the last decade, you probably never met Daniel Schwartz. But as you called our toll-free hotline,…
Dear Friends,Like you, we couldn’t wait to say a not-so-fond farewell to 2020! However, in a lot of ways, 2021 brought more of the same. With our in-person educational events and support group meetings…
Welcome to the new gdatf.org! This project has been a long time in the making, and whether you are starting your journey with a new diagnosis – or have already…
Visit us on YouTube to view our new webinar: Graves’ Disease, Thyroid Eye Disease and COVID-19 featuring Dr. Terry Smith and Dr. Don Kikkawa. (Approx. running time is 60 minutes). Stuck…
(Originally posted on July 2, 2019 and February 24, 2021.) If you enjoyed the GDATF’s patient bulletin “What’s Wrong With Me? I’m Not Myself Anymore”, then you won’t want to…
Did you miss our webinar on long-term use of antithyroid medication featuring Dr. Eve Bloomgarden (Northwestern Medicine) and Dr. David Cooper (Johns Hopkins Medicine)? See below to view the program in its entirety on YouTube!…
(Originally posted on December 8, 2020) To our valued community members, Wow, what a decade the last year has been! As 2020 kicked off, the future was so bright, we…
(Originally Posted on August 6, 2020) We were saddened to learn that Dr. Noel R. Rose, a pioneer in the field of autoimmunity and a former GDATF Board member, recently…
Did you know that the GDATF hosts a moderated Facebook group for patients? The group is closed – which means that group posts and comments can only be viewed by members. In order to join the group, visit our Facebook Page. Select…
(Originally posted January 21, 2020 and March 1, 2019) BREAKING NEWS: The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director…